Nestlé to acquire Aimmune Therapeutics in $2.6bn deal
Aimmune’s FDA approved Palforzia therapy is expected to expand Nestlé Health Science’s portfolio to reduce the severity of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Sep 20
Aimmune’s FDA approved Palforzia therapy is expected to expand Nestlé Health Science’s portfolio to reduce the severity of…
11 Jun 20
Vital Proteins will become a part of the Nestlé Health Science portfolio, and will benefit from a variety…
02 Apr 20
GSK has divested the rights for its Horlicks brand and other consumer healthcare nutrition products to Unilever for…
Alphagreen will use its first equity funding to expand its London-based team, develop new CBD products and branch…
06 Jan 20
Atrium Innovations offers pharmaceutical, chemical, and nutritional products including multi-vitamins, fish oils, and antioxidants, enzymes, proteins, and herbal…
24 Sep 19
Guardion aims to increase its existing customer base by making NutriGuard products available to patients directly and through…